| JAKi | Janus kinase inhibitors |
| RA | Rheumatoid arthritis |
| ALC | Absolute lymphocyte count |
| DAS28 | the disease activity score of 28 joints |
| CRP | C-reactive protein |
| ESR | erythrocyte sedimentation rate |
| CDAI | Clinical Disease Activity Index |
| AEs | adverse events |
| ACR | American College of Rheumatology |
| ACPA | anti-citrullinated protein/peptide antibody |
| MACE | major adverse cardiovascular events |
| MTX | methotrexate |
| bDMARD | Biological disease-modifying antirheumatic drug. |
| CVD | cardiovascular disease |